STOCK TITAN

Inspire Medical Systems Inc - INSP STOCK NEWS

Welcome to our dedicated news page for Inspire Medical Systems (Ticker: INSP), a resource for investors and traders seeking the latest updates and insights on Inspire Medical Systems.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Inspire Medical Systems's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Inspire Medical Systems's position in the market.

Rhea-AI Summary
Inspire Medical Systems, Inc. (NYSE: INSP) reported a 40% year-over-year revenue growth in the fourth quarter of 2023, achieving $192.5 million in revenue. The company also achieved a gross margin of 85.4% and reported net income of $14.8 million. Inspire activated 78 new U.S. centers and created 13 new U.S. sales territories in the fourth quarter. The company reaffirmed its full year 2024 revenue guidance to be in the range of $775 million to $785 million, representing year-over-year growth of approximately 24% to 26%. The company also reported financial results for the full year 2023, with revenue of $624.8 million, a 53% increase over full year 2022. Inspire's net loss improved by 53% compared to the previous year, and the company's cash, cash equivalents, and investments increased to $469.5 million as of December 31, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.55%
Tags
earnings
-
Rhea-AI Summary
Inspire Medical Systems, Inc. announces the retirement of Marilyn Carlson Nelson as Chair of its Board of Directors and the appointment of CEO Timothy P. Herbert as the new Board Chair. The company also appoints Gary L. Ellis as the Lead Independent Director. Marilyn Carlson Nelson joined the Board as Chair in 2018, and Timothy P. Herbert has been the President and CEO since May of 2007. The retirement and appointments are set to be effective at the conclusion of the Company’s Annual Meeting of Stockholders scheduled to occur on May 2, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.86%
Tags
none
-
Rhea-AI Summary
Inspire Medical Systems, Inc. (NYSE: INSP) announced the retirement of Jerry C. Griffin, M.D., from its Board of Directors, effective after the Annual Meeting of Stockholders on May 2, 2024. Dr. Griffin, a board member since 2008, contributed significantly to Inspire's growth from a startup to a company with over 60,000 patients treated, 1,000 employees, and $600 million in annual revenue. The board appointed Myriam J. Curet, M.D., as a new member, who currently serves as Executive Vice President and Chief Medical Officer of Intuitive Surgical.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.11%
Tags
none
Rhea-AI Summary
Inspire Medical Systems, Inc. (NYSE: INSP) will release financial results for the fourth quarter and fiscal 2023 after the close of trading on Tuesday, February 6. The management team will host a conference call to discuss the financial results and recent business developments. A webcast of the call will be accessible via the Investor Relations page of the Inspire website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.96%
Tags
conferences earnings
-
Rhea-AI Summary
Inspire Medical Systems, a medical technology company (NYSE: INSP), announced preliminary unaudited results for Q4 and full year 2023, with anticipated revenue of $192.3-192.5 million for Q4 and $624.6-624.8 million for full year 2023. The company also provided initial full year 2024 revenue guidance of $775-785 million, showing a 24-26% increase over 2023. Inspire activated 78 new centers in the U.S. and created 13 new sales territories in Q4 2023, demonstrating significant growth and momentum.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.15%
Tags
none
-
Rhea-AI Summary
Inspire Medical Systems, Inc. (NYSE: INSP) has appointed Dr. Myriam J. Curet, a highly experienced minimally invasive general surgeon, as an independent Director to its Board. Dr. Curet brings extensive expertise in medical device industry R&D, regulatory affairs, and commercialization, having served in leadership roles at Intuitive Surgical, Stanford University, and the University of New Mexico. Her appointment is expected to bring valuable guidance and contributions to Inspire's mission of developing innovative solutions for patients with obstructive sleep apnea (OSA).
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.17%
Tags
management
Rhea-AI Summary
Inspire Medical Systems, Inc. (NYSE: INSP) will present at the 42nd Annual J.P. Morgan Healthcare Conference on January 8, 2024, at 10:30 a.m. Eastern Time. The presentation will be accessible via a live webcast and a webcast replay will be available for two weeks following the presentation.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.05%
Tags
conferences
-
Rhea-AI Summary
Inspire Medical Systems, Inc. (NYSE: INSP) to present at Piper Sandler 35th Annual Healthcare Conference on November 28, 2023. The presentation will focus on the development and commercialization of minimally invasive solutions for obstructive sleep apnea patients. The webcast will be accessible live and via replay on Inspire's Investor website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.25%
Tags
conferences
-
Rhea-AI Summary
Inspire Medical Systems, Inc. (NYSE: INSP) reports 40% year-over-year revenue growth in Q3, 2023, with a revenue of $153.3 million, gross margin of 84.1%, and a net loss of $8.5 million. The company is increasing its full-year revenue guidance to $608 to $612 million, representing a 49% to 50% increase compared to 2022.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-19.66%
Tags
earnings
Rhea-AI Summary
Inspire Medical Systems, Inc. (NYSE: INSP) will present at the Stifel 2023 Healthcare Conference on November 15, 2023. The presentation will be accessible via a live webcast and a replay will be available for two weeks.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.23%
Tags
conferences
Inspire Medical Systems Inc

NYSE:INSP

INSP Rankings

INSP Stock Data

5.47B
29.00M
1.72%
106.61%
5.3%
Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
Professional, Scientific, and Technical Services
Link
US
Golden Valley

About INSP

inspire medical systems, inc. is a medical devices company based out of 9700 63rd avenue north suite 200, maple grove, minnesota, united states.